LENSAR, Inc. announced the first commercial cases performed with the ALLY(TM) Adaptive Cataract Treatment System by Robert Weinstock, MD at The Eye Institute of West Florida. Dr. Weinstock performed 15 laser-assisted cataract surgery cases following the recent installation of his ALLY System. Following ALLY's FDA clearance in June 2022, LENSAR has been working closely with select cataract surgeons and surgery centers to integrate the ALLY System and provide more of their patients with a premium cataract surgery experience.

ALLY's size and ergonomics are designed to facilitate completing the entire cataract surgery procedure in a single, sterile setting, reducing the overall time and improving the experience for the patient and surgeon. In addition to increased efficiencies, ALLY's proprietary features are designed to enable surgeons to deliver improved clinical outcomes. ALLY's Augmented Reality(TM) and Cataract Density Imaging is intended to provide surgeons with a new level of guidance and confidence while performing surgery.

LENSAR expects to install 8 to 12 ALLY Systems in 2022 as part of a controlled, commercial launch.